| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/30/2011 | WO2011079102A1 Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors |
| 06/30/2011 | WO2011079095A1 Prodrugs of [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof |
| 06/30/2011 | WO2011079091A1 (methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses |
| 06/30/2011 | WO2011079087A1 Enac blockers |
| 06/30/2011 | WO2011079077A1 Furin-knockdown and gm-csf-augmented (fang) cancer vaccine |
| 06/30/2011 | WO2011079076A1 Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors |
| 06/30/2011 | WO2011079074A1 Pharmaceutical compositions for deterring misuse, abuse, and diversion |
| 06/30/2011 | WO2011079051A1 Fused heteroaromatic pyrrolidinones as syk inhibitors |
| 06/30/2011 | WO2011079036A1 Benzamide derivatives |
| 06/30/2011 | WO2011079034A1 Extracts from kibdelos porangium as antibacterial agents |
| 06/30/2011 | WO2011079023A1 Methoxatin derivatives |
| 06/30/2011 | WO2011079016A1 Methods of treating hbv and hcv infection |
| 06/30/2011 | WO2011079007A1 Crth2 modulators |
| 06/30/2011 | WO2011079000A1 DERIVATIVES OF 7,8-DIHYDRO-1H-IMIDAZO[2,1-b]PURIN-4(5H)-ONE AND METHODS OF USE THEREOF |
| 06/30/2011 | WO2011078984A1 [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof |
| 06/30/2011 | WO2011078983A1 Treatment for inflammatory bowel disease |
| 06/30/2011 | WO2011078832A1 Effervescent formulations comprising cefixime |
| 06/30/2011 | WO2011078831A1 Improved pharmaceutical compositions comprising cefdinir |
| 06/30/2011 | WO2011078830A1 Rapidly dispersing effervescent formulation |
| 06/30/2011 | WO2011078829A1 Rapidly dispersing pharmaceutical formulation with cefdinir |
| 06/30/2011 | WO2011078828A1 Pharmaceutical composition with high purity |
| 06/30/2011 | WO2011078827A1 The production method for effervescent tablet with cefdinir |
| 06/30/2011 | WO2011078824A1 Dry powder formulation containing tiotropium for inhalation |
| 06/30/2011 | WO2011078823A1 Compositions containing salmeterol, fluticasone and cromoglicic acid |
| 06/30/2011 | WO2011078822A1 Pharmaceutical compositions comprising cefdinir as an active agent |
| 06/30/2011 | WO2011078821A1 Effervescent tablet and granule formulation comprising cefixime |
| 06/30/2011 | WO2011078820A1 Pharmaceutical formulations comprising a third generation cephalosporin and clavulanic acid |
| 06/30/2011 | WO2011078819A1 Amine salts of cefdinir |
| 06/30/2011 | WO2011078818A1 Dry powder combination of tiotropium, a corticosteroid and a cromoglicic acid derivative |
| 06/30/2011 | WO2011078817A1 Combination of tiotropium, mometasone and a cromoglicic acid derivative in dry powder form |
| 06/30/2011 | WO2011078816A1 Dry powder combination of tiotropium, formoterol and a cromoglicic acid derivative |
| 06/30/2011 | WO2011078815A1 Dry powder combination of tiotropium, budesonide and a cromoglicic acid derivative |
| 06/30/2011 | WO2011078799A1 Treatment of bone fracture |
| 06/30/2011 | WO2011078795A1 Bridged morpholino substituted purines |
| 06/30/2011 | WO2011078785A1 Diacylglycerol based alpha-lipoic acid derivatives as antioxidants and agents for blocking food intake |
| 06/30/2011 | WO2011078782A1 A composition comprising of melphalan derivatives and gemcitabine or etoposide useful in the treatment of cancer |
| 06/30/2011 | WO2011078712A1 Combination composition useful for treating cardiovascular diseases |
| 06/30/2011 | WO2011078700A1 Topical oral gel formulations for dental use |
| 06/30/2011 | WO2011078672A1 Molecule for treating an inflammatory disorder |
| 06/30/2011 | WO2011078590A2 Ultraviolet protection composition comprising a blt2 inhibitor |
| 06/30/2011 | WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | WO2011078371A1 Novel 3-hydroxy-5-arylisothiazole derivative |
| 06/30/2011 | WO2011078370A1 Novel parabanic acid derivative and drug having the same as active ingredient |
| 06/30/2011 | WO2011078369A1 Novel aryl urea derivative |
| 06/30/2011 | WO2011078367A1 Emulsion composition |
| 06/30/2011 | WO2011078360A1 Amide compound |
| 06/30/2011 | WO2011078323A1 Active oxygen production inhibitor and anti-hypertensive agent |
| 06/30/2011 | WO2011078312A1 Method for predicting therapeutic effect of chemotherapy on hepatocellular carcinoma patient |
| 06/30/2011 | WO2011078311A1 Antitumor agent or postoperative adjuvant chemotherapeutic agent for treatment of hepatocellular carcinoma |
| 06/30/2011 | WO2011078306A1 Gpr119 agonist |
| 06/30/2011 | WO2011078303A1 Aminopyridine compound |
| 06/30/2011 | WO2011078230A1 3,5-dihydroxy-2-menthenyl stilbene, plant extract containing same, method for collecting same, and application for same |
| 06/30/2011 | WO2011078226A1 Tricyclic compound |
| 06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
| 06/30/2011 | WO2011078204A1 Prophylactic or therapeutic agent for hyperlipemia, and anti-fatigue agent |
| 06/30/2011 | WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same |
| 06/30/2011 | WO2011078134A1 Diacylglycerole acyltranferase gene, and use thereof |
| 06/30/2011 | WO2011078122A1 Anti-cancer agent |
| 06/30/2011 | WO2011078121A1 Anti-cancer agent |
| 06/30/2011 | WO2011078102A1 Novel phenoxypyrimidine derivative |
| 06/30/2011 | WO2011078037A1 Aging marker, method for evaluating aging inhibitor, and cancer inhibitor |
| 06/30/2011 | WO2011077843A1 Atrovastatin-containing coated preparation |
| 06/30/2011 | WO2011077800A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
| 06/30/2011 | WO2011077760A1 Learning motivation improvers |
| 06/30/2011 | WO2011077726A1 4-amino-1,3-thiazine or oxazine derivative |
| 06/30/2011 | WO2011077712A1 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same |
| 06/30/2011 | WO2011077711A1 Novel 2-pyridone derivative and pharmaceutical product containing same |
| 06/30/2011 | WO2011077587A1 Composition for inhibiting allergic diseases |
| 06/30/2011 | WO2011077502A1 Dihydrothieno[2,3-e]indazole compound |
| 06/30/2011 | WO2011077458A1 Formulations of temozolomide for parenteral administration |
| 06/30/2011 | WO2011077452A2 Fast dissolving pharmaceutical composition comprising lornoxicam |
| 06/30/2011 | WO2011077444A1 A new process for the preparation of pure telmisartan |
| 06/30/2011 | WO2011077435A1 Compositions and methods for reducing intraocular pressure |
| 06/30/2011 | WO2011077406A2 Process for preparing tablets comprising 5- hydroxytryptophan and tryptophan |
| 06/30/2011 | WO2011077405A1 Anionic polysaccharides functionalised by a hydrophobic acid derivative |
| 06/30/2011 | WO2011077313A1 Piperidinecarboxamides as mpges - 1 inhibitors |
| 06/30/2011 | WO2011077252A2 Metaxalone cocrystals |
| 06/30/2011 | WO2011077171A1 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity |
| 06/30/2011 | WO2011077159A1 Treatment of osteoporosis |
| 06/30/2011 | WO2011077158A1 Anticoagulant compounds and their use |
| 06/30/2011 | WO2011077133A2 Method of treatment and screening method |
| 06/30/2011 | WO2011077098A1 Inhibitors of akt activity |
| 06/30/2011 | WO2011077063A1 Use of polysaccharides for treating stress and anxiety |
| 06/30/2011 | WO2011077046A1 Phenol derivatives and the pharmaceutical or cosmetic use thereof |
| 06/30/2011 | WO2011077044A1 Phenol derivatives and pharmaceutical or cosmetic use thereof |
| 06/30/2011 | WO2011077043A2 Phenol derivatives and pharmaceutical or cosmetic use thereof |
| 06/30/2011 | WO2011076969A1 Multifunctional compounds modifying alzheimer's disease for the treatment of said disease |
| 06/30/2011 | WO2011076967A1 Use of the compound n-phenyl-n'-(3-methyl-2-butenyl)thiourea for producing medicaments for the treatment of hepatic encephalopathy |
| 06/30/2011 | WO2011076966A1 Fatty acid amide derivatives with amphetamines for the treatment of eating disorders |
| 06/30/2011 | WO2011076946A2 Methods and compositions for the treatment of alzheimer |
| 06/30/2011 | WO2011076930A1 Cyclic hydroxylamine derivatives, their preparation and use as antioxidants |
| 06/30/2011 | WO2011076923A1 Inhibitor for inosine monophosphate (imp) dehydrogenase and/or viral rna polymerase for treatment of hepatitis e |
| 06/30/2011 | WO2011076879A1 Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine |
| 06/30/2011 | WO2011076878A1 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
| 06/30/2011 | WO2011076873A1 Influenza targets |
| 06/30/2011 | WO2011076869A1 Isolated green plant material |
| 06/30/2011 | WO2011076854A1 CLEAVAGE OF β-AMYLOID PRECURSOR PROTEIN |
| 06/30/2011 | WO2011076843A2 Combination therapy for copd |
| 06/30/2011 | WO2011076842A2 Aerosol formulation for copd |
| 06/30/2011 | WO2011076841A2 Combination therapy for copd |